{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T16:47:37Z","timestamp":1648831657549},"reference-count":39,"publisher":"Georg Thieme Verlag KG","issue":"05","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hamostaseologie"],"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:p>COVID-19 bezeichnet eine der schlimmsten Krisen unserer Generation und stellt (nicht nur) f\u00fcr das Gesundheitssystem eine schwer bew\u00e4ltigbare Herausforderung dar. Mortalit\u00e4t und Morbidit\u00e4t sind im Vergleich zu anderen saisonalen Erkrankungen wie der Influenza deutlich erh\u00f6ht. COVID-19 bedroht allerdings nicht die gesamte Bev\u00f6lkerung in gleichem Ma\u00dfe. Hochrisikopatienten sind \u00e4lter und leiden an kardiovaskul\u00e4ren Erkrankungen wie Bluthochdruck, Diabetes mellitus oder einer koronaren Herzerkrankung. Um das Risiko f\u00fcr einen schweren Erkrankungsverlaufs zu quantifizieren bedarf es einer multimodalen Herangehensweise. Verschiedene Risikostratifizierungssysteme stehen zu Verf\u00fcgung um ung\u00fcnstige Verl\u00e4ufe wie Intensivbehandlung oder Gesamtmortalit\u00e4t vorauszusagen. Biomarker wie Troponin-I, D-Dimere und NT pro-BNP kombiniert mit echokardiographischen Parametern wie links- und rechtsventrikul\u00e4rer Pumpfunktion sowie pulmonalarteriellem Druck k\u00f6nnen hilfreich sein um Hochrisikopatienten zu identifizieren, die ein intensiviertes Monitoring und eine stringentere Behandlung ben\u00f6tigen. Da kardiovaskul\u00e4re Risikofaktoren und Komorbidit\u00e4ten von gro\u00dfer Bedeutung zur Absch\u00e4tzung des Verlaufs einer SARS-CoV-2 Infektion sind, k\u00f6nnten alle hospitalisierten COVID-19 Patienten von einer routinem\u00e4\u00dfigen kardiologischen Betreuung durch ein COVID-19-Heart-Team profitieren. Ein fr\u00fchzeitiges Erkennen von (kardiovaskul\u00e4ren) Hochrisikopatienten k\u00f6nnte das Management erleichtern sowie die Prognose einer schweren SARS-CoV-2 Infektion verbessern.<\/jats:p>","DOI":"10.1055\/a-1539-8711","type":"journal-article","created":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T22:45:01Z","timestamp":1628721901000},"page":"350-355","source":"Crossref","is-referenced-by-count":0,"title":["Cardiovascular Risk Assessment in COVID-19"],"prefix":"10.1055","volume":"41","author":[{"given":"Monika","family":"Zdanyte","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Angiology, University Hospital T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominik","family":"Rath","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Angiology, University Hospital T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2021,8,11]]},"reference":[{"issue":"20","key":"ref1","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1001\/jama.2020.6775","article-title":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area","volume":"323","author":"S Richardson","year":"2020","journal-title":"JAMA"},{"issue":"12","key":"ref2","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1055\/s-0040-1715798","article-title":"Guidance for the management of patients with vascular disease or cardiovascular risk factors and COVID-19: position paper from VAS-European Independent Foundation in Angiology\/Vascular Medicine","volume":"120","author":"G T Gerotziafas","year":"2020","journal-title":"Thromb Haemost"},{"issue":"02","key":"ref3","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1016\/j.jinf.2020.04.021","article-title":"Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis","volume":"81","author":"Z Zheng","year":"2020","journal-title":"J Infect"},{"issue":"05","key":"ref4","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1007\/s00134-020-05991-x","article-title":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","volume":"46","author":"Q Ruan","year":"2020","journal-title":"Intensive Care Med"},{"issue":"13","key":"ref5","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention","volume":"323","author":"Z Wu","year":"2020","journal-title":"JAMA"},{"issue":"01","key":"ref6","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/HYPERTENSIONAHA.120.15143","article-title":"Effects of angiotensin II receptor blockers and ACE (angiotensin-converting enzyme) inhibitors on virus infection, inflammatory status, and clinical outcomes in patients with COVID-19 and hypertension: a single-center retrospective study","volume":"76","author":"G Yang","year":"2020","journal-title":"Hypertension"},{"issue":"13","key":"ref7","doi-asserted-by":"crossref","first-page":"382","DOI":"10.15585\/mmwr.mm6913e2","article-title":"Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019 - United States, February 12-March 28, 2020","volume":"69","author":"CDC COVID-19 Response Team","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"104354","DOI":"10.1016\/j.jcv.2020.104354","article-title":"Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome","volume":"127","author":"L Roncon","year":"2020","journal-title":"J Clin Virol"},{"issue":"06","key":"ref9","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.cmet.2020.04.021","article-title":"Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes","volume":"31","author":"L Zhu","year":"2020","journal-title":"Cell Metab"},{"issue":"07","key":"ref10","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.2337\/dc20-0682","article-title":"Obesity is a risk factor for greater COVID-19 severity","volume":"43","author":"F Gao","year":"2020","journal-title":"Diabetes Care"},{"issue":"10","key":"ref11","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1111\/dom.14124","article-title":"Prevalence of co-morbidities and their association with mortality in patients with COVID-19: a systematic review and meta-analysis","volume":"22","author":"A K Singh","year":"2020","journal-title":"Diabetes Obes Metab"},{"issue":"07","key":"ref12","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1001\/jamacardio.2020.0950","article-title":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China","volume":"5","author":"S Shi","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"20","key":"ref13","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1016\/j.jacc.2020.09.549","article-title":"Prognostic impact of prior heart failure in patients hospitalized with COVID-19","volume":"76","author":"J Alvarez-Garcia","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"ref14","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s00392-020-01683-0","article-title":"Impaired cardiac function is associated with mortality in patients with acute COVID-19 infection","volume":"109","author":"D Rath","year":"2020","journal-title":"Clin Res Cardiol"},{"issue":"07","key":"ref15","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1365-2362.2009.02153.x","article-title":"SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS","volume":"39","author":"G Y Oudit","year":"2009","journal-title":"Eur J Clin Invest"},{"issue":"05","key":"ref16","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41569-020-0360-5","article-title":"COVID-19 and the cardiovascular system","volume":"17","author":"Y-Y Zheng","year":"2020","journal-title":"Nat Rev Cardiol"},{"issue":"11","key":"ref17","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1080\/17474086.2020.1831383","article-title":"D-dimer level in COVID-19 infection: a systematic review","volume":"13","author":"M Rostami","year":"2020","journal-title":"Expert Rev Hematol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"F Zhou","year":"2020","journal-title":"Lancet"},{"issue":"05","key":"ref19","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3390\/v12050527","article-title":"Prognostic value of cardiovascular biomarkers in COVID-19: a review","volume":"12","author":"M Aboughdir","year":"2020","journal-title":"Viruses"},{"issue":"07","key":"ref21","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/jmv.25809","article-title":"Analysis of heart injury laboratory parameters in 273 COVID-19 patients in one hospital in Wuhan, China","volume":"92","author":"H Han","year":"2020","journal-title":"J Med Virol"},{"issue":"10","key":"ref22","doi-asserted-by":"crossref","first-page":"e13362","DOI":"10.1111\/eci.13362","article-title":"Predictors of adverse prognosis in COVID-19: a systematic review and meta-analysis","volume":"50","author":"S Figliozzi","year":"2020","journal-title":"Eur J Clin Invest"},{"issue":"18","key":"ref23","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1016\/j.jacc.2020.08.069","article-title":"Characterization of myocardial injury in patients with COVID-19","volume":"76","author":"G Giustino","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"04","key":"ref24","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.annemergmed.2020.07.022","article-title":"Development and validation of the quick COVID-19 severity index: a prognostic tool for early clinical decompensation","volume":"76","author":"A D Haimovich","year":"2020","journal-title":"Ann Emerg Med"},{"issue":"05","key":"ref25","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/thorax.58.5.377","article-title":"Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study","volume":"58","author":"W S Lim","year":"2003","journal-title":"Thorax"},{"issue":"08","key":"ref26","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1001\/jama.2016.0288","article-title":"Assessment of clinical criteria for sepsis: for the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","volume":"315","author":"C W Seymour","year":"2016","journal-title":"JAMA"},{"issue":"08","key":"ref27","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1001\/jamainternmed.2020.2033","article-title":"Development and validation of a clinical risk score to predict the occurrence of critical illness in hospitalized patients with COVID-19","volume":"180","author":"W Liang","year":"2020","journal-title":"JAMA Intern Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"m3339","DOI":"10.1136\/bmj.m3339","article-title":"Risk stratification of patients admitted to hospital with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score","volume":"370","author":"S R Knight","year":"2020","journal-title":"BMJ"},{"issue":"02","key":"ref29","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jinf.2020.05.064","article-title":"A clinical risk score to identify patients with COVID-19 at high risk of critical care admission or death: an observational cohort study","volume":"81","author":"J B Galloway","year":"2020","journal-title":"J Infect"},{"issue":"11","key":"ref30","doi-asserted-by":"crossref","first-page":"e0241825","DOI":"10.1371\/journal.pone.0241825","article-title":"Development and validation of a 30-day mortality index based on pre-existing medical administrative data from 13,323 COVID-19 patients: the Veterans Health Administration COVID-19 (VACO) Index","volume":"15","author":"J T King Jr","year":"2020","journal-title":"PLoS One"},{"issue":"16","key":"ref31","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1001\/jama.2016.3775","article-title":"Development and validation of a prediction rule for benefit and harm of Dual antiplatelet therapy beyond 1 year after percutaneous coronary intervention","volume":"315","author":"R W Yeh","year":"2016","journal-title":"JAMA"},{"issue":"14","key":"ref32","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1136\/hrt.2009.190827","article-title":"The global registry of acute coronary events, 1999 to 2009-GRACE","volume":"96","author":"K AA Fox","year":"2010","journal-title":"Heart"},{"issue":"02","key":"ref33","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1067\/mhj.2001.112404","article-title":"Rationale and design of the GRACE (Global Registry of Acute Coronary Events) Project: a multinational registry of patients hospitalized with acute coronary syndromes","volume":"141","author":"K AA Fox","year":"2001","journal-title":"Am Heart J"},{"issue":"03","key":"ref34","doi-asserted-by":"crossref","first-page":"e0121620","DOI":"10.1371\/journal.pone.0121620","article-title":"Evaluation of clinical risk factors to predict high on-treatment platelet reactivity and outcome in patients with stable coronary artery disease (PREDICT-STABLE)","volume":"10","author":"M Droppa","year":"2015","journal-title":"PLoS One"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"584108","DOI":"10.3389\/fcvm.2021.584108","article-title":"Impaired myocardial function is prognostic for severe respiratory failure in the course of COVID-19 infection","volume":"8","author":"A Petersen-Uribe","year":"2021","journal-title":"Front Cardiovasc Med"},{"issue":"18","key":"ref36","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1016\/j.jacc.2020.03.031","article-title":"Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic","volume":"75","author":"E Driggin","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"03","key":"ref37","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1001\/jama.2020.25864","article-title":"Effect of discontinuing vs continuing angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on days alive and out of the hospital in patients admitted with COVID-19: a randomized clinical trial","volume":"325","author":"R D Lopes","year":"2021","journal-title":"JAMA"},{"issue":"05","key":"ref38","doi-asserted-by":"crossref","first-page":"H1084","DOI":"10.1152\/ajpheart.00217.2020","article-title":"COVID-19, ACE2, and the cardiovascular consequences","volume":"318","author":"A M South","year":"2020","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"14","key":"ref39","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s40265-020-01365-1","article-title":"Is acetylsalicylic acid a safe and potentially useful choice for adult patients with COVID-19?","volume":"80","author":"V Bianconi","year":"2020","journal-title":"Drugs"},{"issue":"05","key":"ref40","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1111\/liv.14435","article-title":"Liver injury during highly pathogenic human coronavirus infections","volume":"40","author":"L Xu","year":"2020","journal-title":"Liver Int"}],"container-title":["H\u00e4mostaseologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-1539-8711.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T22:32:31Z","timestamp":1635201151000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-1539-8711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,11]]},"references-count":39,"journal-issue":{"issue":"05","published-online":{"date-parts":[[2021,10,25]]},"published-print":{"date-parts":[[2021,10]]}},"URL":"https:\/\/doi.org\/10.1055\/a-1539-8711","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0720-9355","2567-5761"],"issn-type":[{"value":"0720-9355","type":"print"},{"value":"2567-5761","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,11]]}}}